Triverus worked with a Life Sciences company on a Data Protection Strategy following the launch of their first commercial product. As part of this engagement, Triverus led the assessment of the client’s information exposure and developed an actionable set of initiatives to address the information protection needs of the client’s growing business.

The Finance Department required a significant effort to reconcile the value of inventory in the inventory sub-ledger and the general ledger. Failure to complete this reconciliation could create risk for Sarbanes-Oxley compliance.

Triverus helped a Life Sciences company understand their current state of information storage, transfer and access, identified potential risks and recommended future state improvements to the organization’s data access and protection.

Triverus led a strategic engagement focused on a new, global, Cloud-based Analytics Platform focused on helping customers leverage their laboratory data, metadata, improve processes and compliance. This platform also implements advanced data analysis to understand and respond to customer usage of both hardware and software products to further develop and deliver enhanced and new products and services to the marketplace. This program focused on enabling three distinct teams to plan and execute high quality software delivery with predictability, adopt lean-agile principles and practices, and work with senior leadership to implement continuous improvement across the organization.

A biotechnology company focusing on clinical stage pharmaceuticals was embarking on a journey to mature how it handles and manages information.  Their goal is to provide access to the appropriate information to the appropriate stakeholders in a secure and readily accessible manner, however based on recent events there was increased urgency to mature the Information Asset Management (IAM) process to address the following challenges:

• Ensure ability to prove artifact lineage and that documents are compliant, consistent, and accurate for FDA submissions.
• Regulatory changes such as General Data Protection Regulation (GDPR) creating new requirements that are difficult to meet within the allowable deadlines.
• Valid users have difficulty finding critical information and are unable to easily determine which document is the gold copy.
• Need to have more control to increase loss prevention, provide early detection and initiate remediation.

At a pre-commercial biotechnology company, Triverus was engaged to execute a Commercial Launch Roadmap engagement. At the time, the client was 12 months from launch but had no IT presence in the organization. Triverus met with business leadership across the commercial, supply chain, medical, market access, finance and HR groups to determine the needs of the biotechnology company and define a right-sized roadmap and budget for launch.

A clinical-stage biopharmaceutical company, focused on developing therapies to improve the lives of patients diagnosed with cancer, received “priority status” for its first approval.  Being fast-tracked for approval heightened the need to quickly transform the company from a clinical development organization to a commercial one.

A biopharmaceutical company had defined a strategic goal of simplifying and enhancing its global regulatory compliance capabilities. The company had adopted several compliance tools but had yet to define the required business rules and configure the tools effectively across their organization.  

Triverus worked with the organization to assess its current data governance capabilities and implement a program to meet the company’s data privacy and records management goals within three quarters.